Determination of phenprocoumon in plasma and urine using at-line solid-phase extraction-capillary electrophoresis.
The use of capillary electrophoresis (CE) for the analysis of biological samples is rather problematic because of the large number of interferences present in the matrix. One of the possibilities to solve such problems is to couple solid-phase extraction (SPE) at-line with CE, a technique developed in our laboratory. In this study at-line SPE-CE is performed for the determination of the anticoagulant phenprocoumon in biological fluids. Plasma samples are injected after the addition of 1 vol.% of formic acid to release the drug from binding proteins, while urine samples can be directly injected. The procedure is linear between 0.2 and 30 microg ml(-1) with a correlation coefficient, r2, of 0.9996. The detection limit in plasma is 0.1 microg ml(-1), which is fully adequate in view of the concentrations, that have to be dealt with in practice. The phenprocoumon concentration in a plasma sample of a patient treated with the anticoagulant was 3.8 microg ml(-1).
Veraart
J R
JR
Vrije Universiteit, Department of General and Analytical Chemistry, Amsterdam, The Netherlands.
Gooijer
C
C
Lingeman
H
H
Velthorst
N H
NH
Brinkman
U A
UA
D019075:Electrophoresis, Capillary / Q000295:instrumentation / Q000379:methods*; D005561:Formates / Q000737:chemistry; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010644:Phenprocoumon / Q000032:analysis* / Q000097:blood / Q000652:urine; D011485:Protein Binding; D012680:Sensitivity and Specificity
D005561:Formates; C030544:formic acid; D010644:Phenprocoumon